ANTM:NYE-Anthem Inc (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 433.34

Change

0.00 (0.00)%

Market Cap

USD 105.18B

Volume

0.91M

Avg Analyst Target

USD 451.08 (+4.09%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2020, it served 43 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. Address: 220 Virginia Avenue, Indianapolis, IN, United States, 46204

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-23 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

N/A

USD423.52B 27.88 17.06
CVS CVS Health Corporation

N/A

USD115.49B 16.02 10.78
CI Cigna Corporation

N/A

USD73.60B 9.46 N/A
HUM Humana Inc

N/A

USD59.35B 24.43 N/A
CNC Centene Corporation

N/A

USD40.37B 56.75 13.67
MOH Molina Healthcare Inc

N/A

USD17.40B 27.87 10.69
BHG Bright Health Group Inc.

N/A

USD5.63B N/A N/A
GTS Triple-S Management Corporatio..

N/A

USD0.84B 8.56 N/A

ETFs Containing ANTM

Symbol Name Weight Mer Price(Change) Market Cap
BIV Vanguard Intermediate-Ter.. 0.00 % 0.05 %

N/A

USD39.05B
IFSU:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

N/A

USD0.06B
XFS-U:CA iShares MSCI Multifactor .. 0.00 % 0.52 %

N/A

N/A
HLGE Hartford Longevity Econom.. 0.00 % 0.44 %

N/A

N/A
TEQI T. Rowe Price Equity Inco.. 0.00 % 0.54 %

N/A

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.55 %

N/A

USD6.73M
IBCZ:XETRA iShares IV Public Limited.. 0.00 % 0.50 %

N/A

USD0.59B
IBCY:XETRA iShares IV Public Limited.. 0.00 % 0.35 %

N/A

USD0.06B
IS07:F iShares IV Public Limited.. 0.00 % 0.55 %

N/A

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.50 %

N/A

USD0.59B
IBCY:F iShares IV Public Limited.. 0.00 % 0.35 %

N/A

USD0.06B
UFSD:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

N/A

USD1.34M
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.50 %

N/A

USD0.58B
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.50 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

N/A

USD1.18B
FSUS:LSE iShares IV Public Limited.. 0.00 % 0.35 %

N/A

USD0.06B
ACWF iShares MSCI Global Multi.. 0.00 % 0.35 %

N/A

USD0.13B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

USD0.05B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

N/A

USD0.04B
XHS SPDR Series Trust - SPDR .. 0.00 % 0.35 %

N/A

USD0.21B
XFS:CA iShares MSCI Multifactor .. 0.00 % 0.51 %

N/A

USD0.07B
XFA:CA iShares MSCI Multifactor .. 0.00 % 0.51 %

N/A

USD9.04M
SPVU Invesco S&P 500 Enhanced .. 0.00 % 0.13 %

N/A

USD0.13B
RYH Invesco S&P 500 Equal Wei.. 0.00 % 0.40 %

N/A

USD0.86B
PBI Pitney Bowes Inc 0.00 % 0.00 %

N/A

USD1.25B
LRGF iShares MSCI USA Multifac.. 0.00 % 0.20 %

N/A

USD1.10B
FDWM Fidelity Covington Trust .. 0.00 % 0.59 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.96% 75% C 81% B-
Dividend Return 1.06% 40% F 27% F
Total Return 36.01% 75% C 80% B-
Trailing 12 Months  
Capital Gain 39.45% 63% D 68% D+
Dividend Return 1.40% 40% F 23% F
Total Return 40.84% 75% C 67% D+
Trailing 5 Years  
Capital Gain 248.09% 75% C 94% A
Dividend Return 13.45% 80% B- 47% F
Total Return 261.54% 75% C 94% A
Average Annual (5 Year Horizon)  
Capital Gain 22.08% 63% D 82% B-
Dividend Return 1.40% 67% D+ 33% F
Total Return 23.49% 63% D 82% B-
Risk Return Profile  
Volatility (Standard Deviation) 22.07% 50% F 53% F
Risk Adjusted Return 106.44% 63% D 93% A
Market Capitalization 105.18B 78% C+ 98% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 19.50 63% D 43% F
Price/Book Ratio 2.92 44% F 35% F
Price / Cash Flow Ratio 9.84 33% F 46% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 15.84% 56% F 71% C-
Return on Invested Capital -3.16% 11% F 19% F
Return on Assets 5.37% 63% D 75% C
Debt to Equity Ratio 58.24% 75% C 57% F
Technical Ratios  
Short Ratio 2.38 78% C+ 48% F
Short Percent 1.14% 78% C+ 76% C
Beta 1.02 13% F 54% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.